![Page Background](./../common/page-substrates/page0182.jpg)
Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved.
The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®.
MS-107
NCCN Guidelines Index
Breast Cancer Table of Contents
Discussion
NCCN Guidelines Version 2.2015
Breast Cancer
2006;47:1202-1208. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16818956.
548. Germann N, Goffinet F, Goldwasser F. Anthracyclines during
pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol
2004;15:146-150. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/14679135.
549. Johnson PH, Gwyn K, Gordon N, et al. The treatment of pregnant
women with breast cancer and the outcomes of the children exposed to
chemotherapy in utero [abstract]. J Clin Oncol 2005;23(Suppl
16):Abstract 540. Available at:
http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/540.
550. Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and
pregnancy. Semin Oncol 1989;16:337-346. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/2678485 .551. Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy.
Pharmacol Ther 1997;74:207-220. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/9336023 .552. Hahn KME, Johnson PH, Gordon N, et al. Treatment of pregnant
breast cancer patients and outcomes of children exposed to
chemotherapy in utero. Cancer 2006;107:1219-1226. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16894524.
553. Gainford MC, Clemons M. Breast cancer in pregnancy: are
taxanes safe? Clinical Oncol (R Coll Radiol) 2006;18:159. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16523825.
554. Garcia-Manero M, Royo MP, Espinos J, et al. Pregnancy
associated breast cancer. Eur J Surg Oncol 2009;35:215-218. Available
at:
http://www.ncbi.nlm.nih.gov/pubmed/18550321 .555. Gonzalez-Angulo AM, Walters RS, Carpenter RJ, et al. Paclitaxel
chemotherapy in a pregnant patient with bilateral breast cancer. Clin
Breast Cancer 2004;5:317-319. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/15507181.
556. Mir O, Berveiller P, Ropert S, et al. Emerging therapeutic options
for breast cancer chemotherapy during pregnancy. Ann Oncol
2008;19:607-613. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17921242.
557. Bader AA, Schlembach D, Tamussino KF, et al. Anhydramnios
associated with administration of trastuzumab and paclitaxel for
metastatic breast cancer during pregnancy. Lancet Oncol 2007;8:79-81.
Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17196514.
558. Fanale MA, Uyei AR, Theriault RL, et al. Treatment of metastatic
breast cancer with trastuzumab and vinorelbine during pregnancy. Clin
Breast Cancer 2005;6:354-356. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16277887.
559. Pant S, Landon MB, Blumenfeld M, et al. Treatment of breast
cancer with trastuzumab during pregnancy. J Clin Oncol 2008;26:1567-
1569. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18349415.
560. Sekar R, Stone PR. Trastuzumab use for metastatic breast cancer
in pregnancy. Obstet Gynecol 2007;110:507-510. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17666645.
561. Shrim A, Garcia-Bournissen F, Maxwell C, et al. Favorable
pregnancy outcome following Trastuzumab (Herceptin) use during
pregnancy--Case report and updated literature review. Reprod Toxicol
2007;23:611-613. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17399946.
562. Waterston AM, Graham J. Effect of Adjuvant Trastuzumab on
Pregnancy. J Clin Oncol 2006;24:321-322. Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16401684.
563. Watson WJ. Herceptin (trastuzumab) therapy during pregnancy:
association with reversible anhydramnios. Obstet Gynecol